Abstract: A system for continuous manageability of Kubernetes clusters is described. A system identifies a node, in a cluster of nodes, which failed to communicate with the cluster of nodes. The system identifies an application, which executed on the identified node, and which enabled continuous availability of cluster management for nodes in the cluster until when the identified node failed. The system identifies another node, which is already in the cluster of nodes, and which satisfies a prerequisite for executing the identified application, as a replacement node for the identified node that failed. The system installs the identified application on the replacement node in the cluster. The system enables, by the replacement node executing the identified application, continuous availability of cluster management for multiple nodes in the cluster.

Abstract: The present disclosure relates to an ionic liquid (IL)-based formulation comprising inhibitors of NADPH oxidases enzymes (Nox's), preferably isoforms 1 and 4, in particular the specific inhibitor 3-cyclohexyl-5-(2,4-dihydroxybenzylidene)-1-methyl-2-thiohydantoin, for the treatment, therapy or prevention of neurological diseases, in particular Parkinson's diseases.

Abstract: A system for continuous manageability of Kubernetes clusters is described. A system identifies a node, in a cluster of nodes, which failed to communicate with the cluster of nodes. The system identifies an application, which executed on the identified node, and which enabled continuous availability of cluster management for nodes in the cluster until when the identified node failed. The system identifies another node, which is already in the cluster of nodes, and which satisfies a prerequisite for executing the identified application, as a replacement node for the identified node that failed. The system installs the identified application on the replacement node in the cluster. The system enables, by the replacement node executing the identified application, continuous availability of cluster management for multiple nodes in the cluster.

Abstract: A method may include: identifying, by an application in a private/public subnet of a virtual private cloud provided by a cloud provider, data to request from a mainframe in an on-premises data center; executing, by the application, an API call for the data to the on-premises data center via a transit gateway; routing, by the transit gateway, the API call to a customer gateway through a private network connection, wherein the customer gateway routes the API call to a load balancer for the on-premises data center; identifying, by the load balancer, one of a plurality of mainframe LPARs in the on-premises data center that stores the data; routing, by the load balancer, the API call to the identified mainframe LPAR, wherein the identified mainframe LPAR is configured to retrieve the data and return the data to the application via the API; and processing, by the application, the data.

Abstract: A hygienic footwear equipment rack unit to maintain a hygienic environment of a premise and to prevent outdoor footwear handling. Slippers for indoor use are provided in various sizes. The slippers may be provided via a conveyor hanger with magnets to secure the slippers. Further provided may be a method of sanitizing outdoor shoes using UV lamps and hot air fans.

Abstract: An artificial down filling material comprising artificial down clusters (1), wherein each of the down clusters (1) comprise a number of filaments (10) arranged side by side in a bundle, the filaments (10) being bonded, preferably melt bonded, together at a bonding location 20, wherein the filaments (10) are self-crimped, multi-component filaments (10), the cross-section of the multi-component filament having at least three corners (211).

Abstract: The new invention foot-care equipment unit is directly related to foot problems and cures from pain, numbness, stiffness, swelling, athlete's foot, blisters, bunios, corns, plantar fasciitis, heel spur, mallet or hammer toe, gout, ingrown toenail, nail hardening, fungal nail infection, plantar wart, stone bruise, morton neuroma, sesamoidits, poor blood circulation, crack heals, blood clots in the foot vain or excessive sweat, and or bad odours are common symptom of foot related issues or causes of poor foot health. The foot-care equipment a hands free solution for practicing random or regularly use of equipment for steaming, fermenting, massaging, cleaning and sanitizing, air blow drying, sterilizing and or scrubbing of foot or the feet's for cure or general health and hygiene as therapy or treatment. The foot-care equipment unit may comprise of semi-automatically functional in cleaning, sanitizing and sterilizing, and or drying of its equipment components for users.

Abstract: A carpet comprising a backing and pile comprising looped or cut tufts of pile yarn attached to and extending from the backing. The pile yarn comprises un-twisted, entangled filaments. The filaments are self-crimped and optionally textured multi-component filaments. A first component of the multi-component filament comprises a first thermoplastic polymer and a second component of the multi-component filaments comprises a second thermoplastic polymer. The first and the second thermoplastic polymer have different yield behavior, whereby the multi-component filaments are self-crimping.

Abstract: An electromagnetic vehicle chassis that is configured with an upper portion and a lower portion wherein the upper portion is movable to a second position and supported therein with an electromagnetic field. The vehicle of the present invention includes a frame having the upper portion movable so as to reduce the overall vehicle weight and as such require less propulsion force resulting in reduced energy consumption. The upper portion of the frame of the present invention is moved into its second position utilizing hydraulic cylinders. Electromagnets present on both the upper portion and lower portion maintain the upper portion in its second position. A battery compartment having a plurality of batteries is operably coupled to the lower portion of the frame. The body of the vehicle includes a plurality of photovoltaic cells electrically coupled to the plurality of batteries.

Abstract: Embodiments of the present disclosure are directed to a heating and cooling system includes a heat exchanger configured to place an airflow and a refrigerant in thermal communication with one another, where the heat exchanger has a coil and a plurality of fans coupled to the coil, and where the plurality of fans is arranged in an array adjacent to the coil.

Abstract: An apparatus includes a first communication interface communicable with a portion of a first network, a second communication interface communicable with a portion of a second network, and a memory. The apparatus is configured to be disposed between the portion of the first network and the portion of the second network. The portion of the first network and the portion of the second network are not otherwise coupled together. The apparatus is switchable between a first mode and a second mode. During the first mode, the apparatus is transparent to data transmission and is configured to store information representing the transmitted data. During the second mode, the apparatus is configured to block data transmission between the first network and the second network via the apparatus so as to form an enclaved network segment of the portion of the first network.

Abstract: An apparatus includes a first communication interface communicable with a portion of a first network, a second communication interface communicable with a portion of a second network, and a memory. The apparatus is configured to be disposed between the portion of the first network and the portion of the second network. The portion of the first network and the portion of the second network are not otherwise coupled together. The apparatus is switchable between a first mode and a second mode. During the first mode, the apparatus is transparent to data transmission and is configured to store information representing the transmitted data. During the second mode, the apparatus is configured to block data transmission between the first network and the second network via the apparatus so as to form an enclaved network segment of the portion of the first network.

Abstract: The present invention relates to the process for the scalable production of Fe3O4/Fe, Sn & Zn doped graphene nanosheets from a naturally abundant seaweed resources such as Sargassum tenerrimum, Sargassum wighti, Ulva faciata, Ulva lactuca and Kappaphycus alvarezii. The granules remained after the recovery of liquid juice from the fresh seaweeds were utilized as a raw material and a deep eutectic solvents (DESs) generated by the complexation of choline chloride and FeCl3, ZnCl2 and SnCl2 were employed as template as well as catalyst for the production graphene nanosheets functionalized with metals. Pyrolysis of the mixture of seaweed granules and DES at 700-900° C. under 95% N2 and 5% H2 atmosphere resulted formation of metal doped graphene sheets with high surface area (120-225 m2·g?1) and high electrical conductivity 2384 mS·m?1 to 2400 mS·m?1. The nanosheets thus obtained could remove substantial amount of fluoride from fluoride contaminated drinking water (95-98%).

Abstract: Embodiments of the present disclosure are directed to a heating and cooling system includes a heat exchanger configured to place an airflow and a refrigerant in thermal communication with one another, where the heat exchanger has a coil and a plurality of fans coupled to the coil, and where the plurality of fans is arranged in an array adjacent to the coil.

Abstract: The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.

Abstract: The present invention relates to pharmaceutical compositions comprising dimethyl fumarate and a pharmaceutically acceptable agent which inhibits the enzyme catalyzed degradation of dimethyl fumarate.

Abstract: The present invention relates to pharmaceutical compositions comprising dimethyl fumarate and a pharmaceutically acceptable agent which inhibits the enzyme catalyzed degradation of dimethyl fumarate.

Abstract: The present invention relates to the process for the scalable production of Fe3O4/Fe, Sn & Zn doped graphene nanosheets from a naturally abundant seaweed resources such as Sargassum tenerrimum, Sargassum wighti, Ulva faciata, Ulva lactuca and Kappaphycus alvarezii. The granules remained after the recovery of liquid juice from the fresh seaweeds were utilized as a raw material and a deep eutectic solvents (DESs) generated by the complexation of choline chloride and FeCl3, ZnCl2 and SnCl2 were employed as template as well as catalyst for the production graphene nanosheets functionalized with metals. Pyrolysis of the mixture of seaweed granules and DES at 700-900° C. under 95% N2 and 5% H2 atmosphere resulted formation of metal doped graphene sheets with high surface area (120-225 m2·g?1) and high electrical conductivity 2384 mS·m?1 to 2400 mS·m?1. The nanosheets thus obtained could remove substantial amount of fluoride from fluoride contaminated drinking water (95-98%).

Abstract: An apparatuses, systems, computer program products, and methods are disclosed for discovering, evaluating and storing data related to marked response area on manually filled paper forms, the method comprising steps of capturing one or more digital image of a data filled physical paper forms or automated generated paper form with filled in data, fixing the perspective of the captured data filled paper form digital image, identifying the form regions in the data filled paper forms' digital image, obtaining the metadata of the captured data filled paper form digital image, fetching relevant form data from one or more databases and servers, and adjusting the response area co-ordinates on the image and process each response on the image to identify if it is marked or not.

Abstract: The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.